โ† All Topics / ade

FDA ADE reports for Fuzapladib

ade_fuzapladib_adverse_events

ade en 2026-07-22

Fuzapladib โ€” FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Fuzapladib is a active ingredient.

Total reports

Fuzapladib: 395

Reports by species (top entries)

  • Dog 369
  • Cat 3
  • Human 3

Top reported reactions (VEDDRA terms, top entries)

  • Death by euthanasia 86
  • Lack of efficacy - NOS 55
  • Death 39
  • Vomiting 38
  • Elevated total bilirubin 37
  • Abnormal ultrasound finding 36
  • Anorexia 36
  • Lethargy (see also Central nervous system depression in Neurological) 35
  • Diarrhoea 32
  • Elevated serum alkaline phosphatase (ALP) 32

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b15.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).